Institute of Biology, Taras Shevchenko National University, Kyiv, Ukraine.
Department of Endocrinology, Bogomolets National Medical University, Kyiv, Ukraine.
Biomed Pharmacother. 2016 Dec;84:1383-1392. doi: 10.1016/j.biopha.2016.10.060. Epub 2016 Oct 29.
In our previous works, the important therapeutic properties of nanocrystalline cerium dioxide such as strong antioxidant ability, prebiotical and antibiotic activity were shown. Such properties were obtained due to stabilization of nanoparticles with precise size 3-7nm. Such modification of nanocrystalline cerium dioxide has contributed to its remarkable efficacy and low toxicity. We have carried out the investigation of toxicity of the nanodrug and revealed that in the condition of the acute toxicity test, LD 50 was 2000mg/kg when it was administered per os. This indicator is approximately 1000 times greater than effective dose of the compound that proved the possibility of its usage for humans. Considering the strong antioxidant properties of this substance, we have performed the investigation of the influence of nanocrystalline cerium dioxide on the erosive-ulcerative lesions in gastric mucosa of rats induced by Selye's restraint stress. It was established that the studied compound significantly reduced the lesions area by 58.3% (p<0.05) induced by Selye's restraint stress. The attenuation of inflammation and decrease of lipid peroxidation in the conditions of gastric lesions and prophylactic administration of nanocrystalline cerium dioxide were shown. That was confirmed by the decrease of pro-inflammatory cytokines content (interleukin (IL) 1β, 12B p40) and raise of anti-inflammatory cytokines content (IL-10 and transforming growth factor β). Measurement of lipid peroxidation products has proved the antioxidant properties of nanocrystalline cerium dioxide as it decreased the content of conjugated dienes and thiobarbituric acid active products in the conditions of gastric ulceration induced by stress.
在我们之前的工作中,已经证明了纳米氧化铈的一些重要治疗特性,如强大的抗氧化能力、益生元和抗生素活性。这些特性是通过将纳米粒子稳定在 3-7nm 的精确尺寸来获得的。纳米氧化铈的这种修饰有助于提高其疗效和降低毒性。我们已经对纳米药物的毒性进行了研究,结果表明,在急性毒性试验中,口服给予 2000mg/kg 时,LD50 为 2000mg/kg。这一指标大约是已证明对人体有效剂量的 1000 倍,表明其具有应用于人体的可能性。鉴于该物质具有强大的抗氧化特性,我们研究了纳米氧化铈对塞莱氏束缚应激诱导的大鼠胃黏膜糜烂性溃疡的影响。结果表明,研究化合物可使塞莱氏束缚应激诱导的病变面积显著减少 58.3%(p<0.05)。在胃损伤和预防性给予纳米氧化铈的情况下,炎症减轻和脂质过氧化降低。这一点通过促炎细胞因子含量(白细胞介素 (IL) 1β、12B p40)的降低和抗炎细胞因子含量(IL-10 和转化生长因子 β)的升高得到证实。脂质过氧化产物的测量证明了纳米氧化铈的抗氧化特性,因为它降低了应激诱导的胃溃疡条件下共轭二烯和硫代巴比妥酸活性产物的含量。